NYC Bioscience Newsletter connects you to the latest information on Bio & Health Tech NYC.
April 23, 2014
NYC Bioscience Newsletter

SBIR/STTR and NIH Proposal Preparation Workshop

Learn more about SBIR/STTR funding and the basics of proposal preparation from Lisa Kurek, nationally recognized SBIR expert. This full-day session will take place on Friday, May 9th at Mount Sinai School of Medicine.

In The News


Pilot Health Tech NYC Matchmaking Sessions ›
On March 11 & 12 at NY Genome Center, the Pilot Health Tech NYC program hosted two days of matchmaking health tech startups with healthcare leaders. Through 300+ brief, curated meetings, hospitals and large employers were exposed to a wide range of health and wellness technologies that promise to improve New Yorkers’ lives.

Apply now to Pilot for up to $100,000 each in matching funding for innovative health tech pilot projects in New York City. Health tech startups, healthcare providers, foundations, employers, pharma companies, and other organizations may be eligible. The deadline is May 23rd.

Exosome Diagnostics Raises $27M B Round ›
NYC-based Exosome Diagnostics is a leading developer of fluid-based molecular diagnostic tests for use in personalized medicine. Co-leading the $27M financing were investors QIAGEN and Arcus Ventures.

Everyday Health Raises $100M in IPO ›
NYC-based Everyday Health is a leading provider of digital health and wellness solutions. During 2013, an estimated average of 43 million consumers and 500,000 healthcare professionals engaged with Everyday Health’s health and wellness properties each month. Last month, the company raised approximately $100M in an IPO.

Immunovent: A Novel Approach to Allergy Testing ›
NYC-based Immunovent is a Cornell Medical School startup focused on the next-generation of allergy diagnosis. The company is developing the Local Allergy Mucosal Brush Test (LAMB-Dx) as the first quantitative allergy diagnostic that will enable physicians to accurately test for both airborne and food allergies precisely where the clinical symptoms are occurring, in the mouth and nose. The company is based at Harlem Biospace and has been active in several NYCEDC initiatives including ELAB NYC, SBIR Impact NYC.

Harlem Biospace Conducts Open House ›
On March 24th, Harlem Biospace (Hb) conducted an open house and demo session for elected officials, industry leaders, and startups. While Harlem Biospace is currently fully occupied with 19 companies, it is accepting applications for its waitlist on a rolling basis.

NewYorkBIO-Conference 2014 ›
This NYC-based business meeting draws over 800 attendees each year and is designed to bring together the senior industry, academic, and political leadership to learn, discuss, debate, and influence the emergence and maturation of the region’s bioscience industry. For 2014, the event has moved to Time Warner Center on Columbus Circle for an incredible view of Central Park.

Generic Engineering (GEN) News Ranks NYC As a Top BioPharma Cluster ›
GEN just released its report on the Top 10 U.S. Biopharma Clusters-NYC was ranked the fifth biopharma cluster just behind Boston, San Diego, and San Francisco and ahead of Research Triangle Park, NC (RTP).

Upcoming Events

April 17
Investing in Life Science – A Primer for Investors 
Harlem Biospace
423 W 127th St
April 24
Licensing Executive Society - Digital Health - It's Good for You
Holland & Knight
31 W 52nd St, 11th Floor
April 30 – May 1
DLDnyc
IAC Building
555 W 18th St
May 6
NYC Tech Connect
Memorial Sloan-Kettering Cancer Center
430 E 67th Street
May 7
NYC Healthcare Business Leaders
Lennox Hill Hospital
100 E 77th St, Hearth Room
May 9
SBIR/STTR and NIH Proposal Preparation Workshop
Mt. Sinai School of Medicine.
1428 Madison Ave
May 9
The Biology of Aging
NY Academy of Sciences
250 Greenwich St
May 13
NYC MedTech
405 Lexington Ave
May 13-14
HxRefactored
New York Marriott at the Brooklyn Bridge
333 Adams Street, Floor 2
May 14 – 15
NY BIO Conference 2014
10 on the Park
60 Columbus Circle, 10th Floor
May 23
Pilot Health Tech NYC
Submission Deadline
June 17
New York Venture Summit
Digital Sandbox
55 Broad Street, 4th Floor
July 24
Life Sciences Market Symposium
620 8th Avenue
Sept 8-9
15th International Conference on Alzheimer’s Drug Discovery
Hyatt Regency 
2 Exchange Pl, Jersey City

Leasing Opportunities

Who's Hiring in NYC Bioscience

To post a position, please email biojobs@nycedc.com.

For more information on the latest Bioscience activities in New York City and how NYCEDC can assist your business, visit us at www.nycbiotech.org or contact Lenzie Harcum at 212-312-3806.

You May Also Like...

A New Biotech Incubator Concept, Right in Manhattan

Harlem Biospace (Hb), a new biotech incubator and the first of its kind in New York City to offer affordable, shared, wet-lab space for competitively-selected entrants, opened in November 2013. Learn more at harlembiospace.com.

New York City's $100 Million Investment In Life Sciences

The Life Sciences Funding Initiative is the capstone to a portfolio of City initiatives designed to champion New York City's early-stage life sciences ecosystem. The fund seeks to launch 15 to 20 breakthrough life science ventures by 2020.

Subscribe to the NYC Bioscience Newsletter
           


Edit your subscription
Unsubscribe lharcum@nycedc.com from this list

Mailing Address
NYCEDC
110 William Street
New York, NY 10038

Add us to your address book